Bioactivity | Ampreloxetine (TD-9855) is a potent and orally active norepinephrine (NE) and serotonin 5-HT inhibitor. Ampreloxetine has the potential for the research of neurogenic orthostatic hypotension[1][2]. |
In Vivo | Ampreloxetine (0.3, 1, 5, 10, 30, 60 mg/kg; p.o.; single dose) 在大鼠血浆中的 EC50 值分别为 11.7ng/mL 和 50.8ng/mL[1]。 Animal Model: |
Name | Ampreloxetine |
CAS | 1227056-84-9 |
Formula | C18H18F3NO |
Molar Mass | 321.34 |
Transport | Room temperature in continental US; may vary elsewhere. |
Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Reference | [1]. Smith JA, et al. Preclinical to clinical translation of CNS transporter occupancy of TD-9855, a novel norepinephrine and serotonin reuptake inhibitor. Int J Neuropsychopharmacol. 2014 Dec 13;18(2):pyu027. [2]. Kaufmann H, et al. Safety and efficacy of ampreloxetine in symptomatic neurogenic orthostatic hypotension: a phase 2 trial. Clin Auton Res. 2021 Dec;31(6):699-711. |